|
Marker Therapeutics inc (MRKR) |
|
Marker Therapeutics inc
MRKR's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Marker Therapeutics Inc growth rates, revenue grew
by 53.31 % in II. Quarter 2024 from the same quarter a year ago.
Ranking at No. 1648
Major Pharmaceutical Preparations industry recorded
growth of revenues by 5.15 %
Marker Therapeutics Inc faced net loss in contrast to the net income a year ago in II. Quarter 2024
• More on MRKR's Growth
|
|
Marker Therapeutics Inc realized a net loss in trailing twelve months.
Marker Therapeutics Inc realized cash reduction of $ -1.16 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 162.34.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.49.
• More on MRKR's Valuation
|
|
|
|
|
Marker Therapeutics Inc realized net loss in trailing twelve months.
Marker Therapeutics Inc realized cash outflow of $ -1.16per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 162.34.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.49.
Marker Therapeutics Inc Price to Book Ratio is at 3.81 lower than Industry Avg. of 83.74. and higher than S&P 500 Avg. of 0
• More on MRKR's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com